Anti-thyroid autoantibodies and hepatitis C virus
✍ Scribed by Nicole Colas-Linhart; Bernard Bok; Patrick Marcellin; Michèle Pouteau; Jean-Pierre Bengamou
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 210 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We have built a model of the specificity pocket of the protease of hepatitis C virus on the basis of the known structures of trypsin-like serine proteases and of the conservation pattern of the protease sequences among various hepatitis C strains. The model allowed us to predict that the substrate o
## Autoantibodies in human immunodeficiency virusinfected patients with and without concurrent hepatitis C infection Infections caused by human immunodeficiency virus (HIV) and hepatitis C virus (HCV), 2 blood-transmitted and frequently coinfecting agents, have been associated with autoantibody pr
We are very pleased about the interest and the debate elicited by our article "Acute viral hepatitis increases liver stiffness values measured by transient elastography" 1 and we read with attention Ze-Zhou Song's letter to the editor. First of all, we must say that we are very sorry that Dr. Song h
## Abstract The biological variation of anti‐TPO and anti‐Tg autoantibodies was studied in 17 clinically and biochemically stable female patients with autoimmune thyroid disease (AITD), at regular monthly intervals over a period of 6 consecutive months. The mean and standard deviation (SD), within‐
RNA interference (RNAi) is being evaluated as an alternative therapeutic strategy for hepatitis C virus (HCV) infection. The use of viral vectors encoding short hairpin RNAs (shRNAs) has been the most common strategy employed to provide sustained expression of RNAi effectors. However, overexpression